Farkas Vánky

3.4k total citations · 1 hit paper
104 papers, 2.6k citations indexed

About

Farkas Vánky is a scholar working on Immunology, Cardiology and Cardiovascular Medicine and Oncology. According to data from OpenAlex, Farkas Vánky has authored 104 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Immunology, 38 papers in Cardiology and Cardiovascular Medicine and 24 papers in Oncology. Recurrent topics in Farkas Vánky's work include Immunotherapy and Immune Responses (35 papers), Immune Cell Function and Interaction (32 papers) and Cardiac, Anesthesia and Surgical Outcomes (22 papers). Farkas Vánky is often cited by papers focused on Immunotherapy and Immune Responses (35 papers), Immune Cell Function and Interaction (32 papers) and Cardiac, Anesthesia and Surgical Outcomes (22 papers). Farkas Vánky collaborates with scholars based in Sweden, Switzerland and China. Farkas Vánky's co-authors include Eva Klein, E. Klein, Jan Stjernswärd, B. M. Vose, Mikael Jondal, R. Sealy, Hans Wigzell, Rolf Svedjeholm, Erik Håkanson and Hannah Ben‐Bassat and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and The Journal of Experimental Medicine.

In The Last Decade

Farkas Vánky

101 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

LYMPHOPENIA AND CHANGE IN DISTRIBUTION OF HUMAN B AND T LYMPHOCYTES IN PERIPHERAL BLOOD INDUCED BY IRRADIATION FOR MAMMARY CARCINOMA

1972 390 citations Jan Stjernswärd, Farkas Vánky et al. profile →

Peers

Countries citing papers authored by Farkas Vánky

Since Specialization

Citations

This map shows the geographic impact of Farkas Vánky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Farkas Vánky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Farkas Vánky more than expected).

Fields of papers citing papers by Farkas Vánky

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Farkas Vánky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Farkas Vánky. The network helps show where Farkas Vánky may publish in the future.

Co-authorship network of co-authors of Farkas Vánky

This figure shows the co-authorship network connecting the top 25 collaborators of Farkas Vánky. A scholar is included among the top collaborators of Farkas Vánky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Farkas Vánky. Farkas Vánky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Sex difference in aortic root replacement with a stentless bioprosthesis 2025 ·European Journal of Cardio-Thoracic Surgery ·(unknown), (unknown), Philippe Timmermans, Natalie Glaser, (unknown), Farkas Vánky, Tómas Guðbjartsson, Rune Haaverstad, (unknown), Ulrik Sartipy, Robert J.M. Klautz, Morten Smerup, Jesper Hjortnaes, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1
2	Effect of cryothermic and radiofrequency Cox‐Maze IV ablation on atrial size and function assessed by 2D and 3D echocardiography, a randomized trial. To freeze or to burn 2023 ·Clinical Physiology and Functional Imaging ·(unknown), Farkas Vánky, Meriam Åström Aneq	3
3	Evaluation of left ventricular diastolic function in patients operated for aortic stenosis 2022 ·PLoS ONE ·(unknown), Eva Nylander, (unknown), Rolf Svedjeholm, Jan Engvall, Jonas Holm, Eva Maret, Farkas Vánky	2
4	Effect of glutamate infusion on NT-proBNP after coronary artery bypass grafting in high-risk patients (GLUTAMICS II): A randomized controlled trial 2022 ·PLoS Medicine ·(unknown), (unknown), A. Holmgren, Farkas Vánky, Örjan Friberg, (unknown), Rolf Svedjeholm	2
5	Biochemical response to cryothermal and radiofrequency exposure of the human myocardium at surgical ablation of atrial fibrillation: a randomized controlled trial 2020 ·SHILAP Revista de lepidopterología ·(unknown), Meriam Åström Aneq, Giannis Spyrou, Helena Enocsson, Emmanouil Charitakis, Farkas Vánky	3
6	NT-proBNP and postoperative heart failure in surgery for aortic stenosis 2019 ·Open Heart ·(unknown), Farkas Vánky, (unknown), Jonas Holm, Yanqi Yang, Rolf Svedjeholm	6
7	Rise and fall of NT-proBNP in aortic valve intervention 2018 ·Open Heart ·(unknown), Jonas Holm, Rolf Svedjeholm, Farkas Vánky	12
8	Impact of underlying heart disease per se on the utility of preoperative NT-proBNP in adult cardiac surgery 2018 ·PLoS ONE ·(unknown), (unknown), Jonas Holm, Farkas Vánky, (unknown), Rolf Svedjeholm	7
9	Evaluation of the Valve Academic Research Consortium-2 Criteria for Myocardial Infarction in Transcatheter Aortic Valve Implantation: A Prospective Observational Study 2015 ·PLoS ONE ·Lennart Nilsson, (unknown), (unknown), Farkas Vánky	7
10	EuroSCORE II and N-terminal pro-B-type natriuretic peptide for risk evaluation: an observational longitudinal study in patients undergoing coronary artery bypass graft surgery 2014 ·British Journal of Anaesthesia ·Jonas Holm, (unknown), Farkas Vánky, Örjan Friberg, Erik Håkanson, Sten Walther, Rolf Svedjeholm	31
11	GLUTAMICS—a randomized clinical trial on glutamate infusion in 861 patients undergoing surgery for acute coronary syndrome 2012 ·Journal of Thoracic and Cardiovascular Surgery ·(unknown), Erik Håkanson, Örjan Friberg, (unknown), Jonas Holm, Farkas Vánky, (unknown), (unknown), Rajiv Sharma, Rolf Svedjeholm	17
12	Left and right ventricular function in aortic stenosis patients 8 weeks post-transcatheter aortic valve implantation or surgical aortic valve replacement 2011 ·European Heart Journal - Cardiovascular Imaging ·Lena Forsberg, (unknown), Farkas Vánky, Niels Erik Nielsen, Jan Engvall, Eva Nylander	37
13	The S-100B substudy of the GLUTAMICS trial: Glutamate infusion not associated with sustained elevation of plasma S-100B after coronary surgery 2009 ·Clinical Nutrition ·(unknown), Jonas Holm, Erik Håkanson, Örjan Friberg, (unknown), Farkas Vánky, Rolf Svedjeholm	7
14	Transforming growth factor β , (TGFβ) secreted by immunogenic ex vivo human carcinoma cells, counteracts the activation and inhibits the function of autologous cytotoxic lymphocytes. Pretreatment with interferon γ and tumor necrosis factor α reduces the production of active TGFβ 1998 ·Cancer Immunology Immunotherapy ·Noémi Nagy, Farkas Vánky	11
15	Detection of polypeptides associated with the histopathological differentiation of primary lung carcinoma 1995 ·British Journal of Cancer ·Takashi Hirano, Bo Franzén, (unknown), Ken Okuzawa, Ayodele Alaiya, Farkas Vánky, Luís Vaz Rodrigues, Y Ebihara, Hajime Kato, Gert Auer	31
16	Application of isoelectric focusing for studies of major histocompatibility complex class I antigen expression on human carcinomas and sarcomas 1991 ·Cancer Immunology Immunotherapy ·(unknown), Farkas Vánky, E. Klein	7
17	Expression of interleukin-2 receptor on blood lymphocytes stimulated with allogeneic lymphocytes or autologous tumor cells 1990 ·Cancer Immunology Immunotherapy ·György Stuber, Farkas Vánky, Éva Pócsik, M. Benczúr, E. Klein	3
18	Lysis of tumor biopsy cells by autologous T lymphocytes activated in mixed cultures and propagated with T cell growth factor. 1982 ·The Journal of Experimental Medicine ·Farkas Vánky, (unknown), (unknown), Maria G. Masucci, E. Klein	64
19	Functional studies on tumor-infiltrating lymphocytes in man. 1977 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·E. Klein, Erik Svedmyr, Mikael Jondal, Farkas Vánky	10
20	Stimulation of lymphocytes by autochthonous cancer. 1972 ·PubMed ·Jan Stjernswärd, Farkas Vánky	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact